1985
DOI: 10.1016/s0022-5347(17)47330-7
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear Androgen Receptor Content in Biopsy Specimens From Histologically Normal, Hyperplastic, and Cancerous Human Prostatic Tissue

Abstract: Androgen receptors (ARn) were assayed in nuclear extracts of prostatic biopsies from 60 patients with benign prostatic hyperplasia (BPH) and 82 patients with prostatic cancer (PC), with an exchange assay using heparin extraction, labelling with 3H-R1881, and protamine sulphate precipitation. The content of ARn of BPH biopsies (38 f 34 fmol/mg protein [mean f SD]; n = 70) was not different from that of PC biopsies (39 f 32 fmol/mg protein; n = 115). Biopsies showing essentially normal prostatic tissue had a low… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
4
0

Year Published

1986
1986
2006
2006

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 8 publications
(15 reference statements)
1
4
0
Order By: Relevance
“…The binding data (Kd and capacity) of the PC-82 androgen receptor are quite comparable to those published for the other human prostatic carcinoma models, such as the in vivo HONDA tumor [17] and the in vitro cell line LNCaP [18,19]. In addition, the data are also comparable to those published for human carcinomas, BPH-tissue, and normal prostate tissues [20,21]. Of the tested androgens R1881 showed the highest affinity for the androgen receptor, but this steroid was not analyzed for growth stimulatory action on the tumor.…”
Section: Discussionsupporting
confidence: 79%
“…The binding data (Kd and capacity) of the PC-82 androgen receptor are quite comparable to those published for the other human prostatic carcinoma models, such as the in vivo HONDA tumor [17] and the in vitro cell line LNCaP [18,19]. In addition, the data are also comparable to those published for human carcinomas, BPH-tissue, and normal prostate tissues [20,21]. Of the tested androgens R1881 showed the highest affinity for the androgen receptor, but this steroid was not analyzed for growth stimulatory action on the tumor.…”
Section: Discussionsupporting
confidence: 79%
“…Androgen receptors (AR), although intuitively implicated in prostatic dysfunction, have not yet been definitively involved as evidenced by disagreement concerning their relevance to prostate pathology [17,[20][21][22][23][24]45,46]. The necessity to assay AR within a reproducible framework has been emphasised [47], but achievement of such an ideal is hindered by nonuniform distribution of AR among areas of the same prostate [48], between different prostate tissue types [15][16][17]49301, and possibly among different subnuclear compartments [8,9,50,51].…”
Section: Discussionmentioning
confidence: 99%
“…Control slides were treated in an identical manner, except that nonspecific mouse antibodies were used as the first step. (43,44). Double-labeling studies.…”
Section: Methodsmentioning
confidence: 99%